Headlines
- 5 Stocks Poised for Breakoutsat TheStreet(Fri, Jun 7)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a VotEDGAR Online(Tue, Jun 4)
- 2 Buys, 1 Sell In This Year's Biotech Surgeat Seeking Alpha(Thu, May 30)
- New Memoir by Singer/Songwriter Kristie Salerno Kent Follows Her Journey as a Multiple Sclerosis Patient AdvocateBusiness Wire(Wed, May 29)
- Acorda to Present New Research on AMPYRA® at Fifth Cooperative Meeting of CMSC and ACTRIMSBusiness Wire(Tue, May 28)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, May 28)
- Alkermes Earnings Beat Estimates, But Outlook Unclearat Investor's Business Daily(Thu, May 23)
- Alkermes posts 4Q profit as royalty payments riseAP(Thu, May 23)
- Alkermes Earnings Seen Rising, But Sales Uncertainat Investor's Business Daily(Wed, May 22)
- Additional Patent for Acorda's AmpyraZacks(Wed, May 22)
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue, May 21)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, May 21)
- 4 Healthcare Stock Stories Prescribed For Investorsat Wall St. Cheat Sheet(Mon, May 20)
- Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage StrengthsBusiness Wire(Mon, May 20)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, May 20)
Press Releases
- New Memoir by Singer/Songwriter Kristie Salerno Kent Follows Her Journey as a Multiple Sclerosis Patient AdvocateBusiness Wire(Wed, May 29)
- Acorda to Present New Research on AMPYRA® at Fifth Cooperative Meeting of CMSC and ACTRIMSBusiness Wire(Tue, May 28)
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue, May 21)
Reports
- ACOR: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Jun 19)
- Trading Report for (ACOR). A detailed report, including free correlated market...Stock Traders Daily(Jun 19)
